» Articles » PMID: 39501175

Diagnostic Significance of Ultrasound Characteristics in Discriminating Follicular Thyroid Carcinoma from Adenoma

Overview
Journal BMC Med Imaging
Publisher Biomed Central
Specialty Radiology
Date 2024 Nov 5
PMID 39501175
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland and has a greater propensity for haematogenous metastasis. However, the preoperative differentiation of FTC from follicular thyroid adenoma (FTA) is not well established. Certain ultrasound characteristics are associated with an increased risk of thyroid malignancy, but mainly for papillary thyroid cancers and not for FTC.

Objectives: This retrospective study aimed to evaluate the ultrasound characteristics of FTC and the value of ultrasound characteristics in differentiating FTC from FTA.

Methods: A total of 96 patients with pathologically confirmed FTC or FTA who underwent preoperative thyroid ultrasound were included in this study. The ultrasound and pathological characteristics were evaluated.

Results: Our data revealed that the incidences of lesions with tubercle-in-nodule, spiculated/microlobulated margins, mixed vascularization, egg-shell calcification, central stellate scarring, extension toward the capsule and chronic lymphocytic thyroiditis were significantly higher in the FTC group (all p < 0.05). After adjusting for confounding factors, lesions with mixed vascularization (odds ratio [OR]: 2.038, P = 0.019), central stellate scarring (OR: 87.992, P = 0.007), extension toward the capsule (OR: 22.587, P = 0.010), and chronic lymphocytic thyroiditis (OR: 9.195, P = 0.006) were independently associated with FTC. Furthermore, combined with chronic lymphocytic thyroiditis, mixed vascularization, central stellate scarring, and extension toward the capsule showed high discriminatory accuracy in predicting FTC (AUC: 0.914; sensitivity: 96.5%; specificity: 71.8%; p < 0.001).

Conclusions: In combination with chronic lymphocytic thyroiditis, mixed vascularization, central stellate scarring, and extension toward the capsule have greater accuracy in differentiating FTCs from FTAs.

References
1.
Conzo G, Avenia N, Ansaldo G, Calo P, De Palma M, Dobrinja C . Surgical treatment of thyroid follicular neoplasms: results of a retrospective analysis of a large clinical series. Endocrine. 2016; 55(2):530-538. DOI: 10.1007/s12020-016-0953-2. View

2.
Li W, Song Q, Lan Y, Li J, Zhang Y, Yan L . The Value of Sonography in Distinguishing Follicular Thyroid Carcinoma from Adenoma. Cancer Manag Res. 2021; 13:3991-4002. PMC: 8139727. DOI: 10.2147/CMAR.S307166. View

3.
Luvhengo T, Bombil I, Mokhtari A, Moeng M, Demetriou D, Sanders C . Multi-Omics and Management of Follicular Carcinoma of the Thyroid. Biomedicines. 2023; 11(4). PMC: 10135557. DOI: 10.3390/biomedicines11041217. View

4.
Caturegli P, De Remigis A, Rose N . Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014; 13(4-5):391-7. DOI: 10.1016/j.autrev.2014.01.007. View

5.
Grani G, Lamartina L, Durante C, Filetti S, Cooper D . Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 2017; 6(6):500-514. DOI: 10.1016/S2213-8587(17)30325-X. View